Kezar Life Sciences
78 hedge funds and large institutions have $109M invested in Kezar Life Sciences in 2020 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 27 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
8% less funds holding
Funds holding: 85 → 78 (-7)
41% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 17
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
78
Holding in Top 10
–
Calls
$53K
Puts
$1K
Top Buyers
| 1 | +$3.28M | |
| 2 | +$1.77M | |
| 3 | +$1.41M | |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$1.41M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$1.38M |
Top Sellers
| 1 | -$1.78M | |
| 2 | -$1.34M | |
| 3 | -$932K | |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$777K |
| 5 |
Renaissance Technologies
New York
|
-$522K |